Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chun

Showing results (421-430 of 1,050) with videos related to

Pageof 105
Sort By:
Cancer|October 15, 2008
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lowerJochen Walz, Alexander Haese, Vincenzo Scattoni, et al.
The Journal of Urology|December 4, 2019
Reply by AuthorsMartin Baunacke, Maria-Luisa Schmidt, Christer Groeben, et al.
International Urology and Nephrology|July 16, 2021
Cystatin C predicts renal function impairment after partial or radical tumor nephrectomyMike Wenzel, Hang Yu, Annemarie Uhlig, et al.
BJU International|February 27, 2016
Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinenceSascha A Ahyai, Tim A Ludwig, Roland Dahlem, et al.
The Prostate|September 26, 2019
Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancerFelix Preisser, Gilberto Coxilha, Alexander Heinze, et al.
Scandinavian Journal of Urology|August 24, 2021
Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomyMike Wenzel, Alexander Kleimaker, Annemarie Uhlig, et al.
BJU International|September 24, 2011
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsyMarco Auprich, Herbert Augustin, Lars Budäus, et al.
Urology|February 3, 2007
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomyAlberto Briganti, Felix K-H Chun, Andrea Salonia, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2009
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissectionAlberto Briganti, Pierre I Karakiewicz, Felix K-H Chun, et al.
International Journal of Molecular Sciences|September 28, 2021
Growth, Proliferation and Metastasis of Prostate Cancer Cells Is Blocked by Low-Dose Curcumin in Combination with Light IrradiationJochen Rutz, Aicha Benchellal, Wajdi Kassabra, et al.
Pageof 105

Showing results (421-430 of 1,050) with videos related to

Sort By:
Pageof 105
Cancer|October 15, 2008
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lowerJochen Walz, Alexander Haese, Vincenzo Scattoni, et al.
The Journal of Urology|December 4, 2019
Reply by AuthorsMartin Baunacke, Maria-Luisa Schmidt, Christer Groeben, et al.
International Urology and Nephrology|July 16, 2021
Cystatin C predicts renal function impairment after partial or radical tumor nephrectomyMike Wenzel, Hang Yu, Annemarie Uhlig, et al.
BJU International|February 27, 2016
Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinenceSascha A Ahyai, Tim A Ludwig, Roland Dahlem, et al.
The Prostate|September 26, 2019
Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancerFelix Preisser, Gilberto Coxilha, Alexander Heinze, et al.
Scandinavian Journal of Urology|August 24, 2021
Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomyMike Wenzel, Alexander Kleimaker, Annemarie Uhlig, et al.
BJU International|September 24, 2011
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsyMarco Auprich, Herbert Augustin, Lars Budäus, et al.
Urology|February 3, 2007
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomyAlberto Briganti, Felix K-H Chun, Andrea Salonia, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2009
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissectionAlberto Briganti, Pierre I Karakiewicz, Felix K-H Chun, et al.
International Journal of Molecular Sciences|September 28, 2021
Growth, Proliferation and Metastasis of Prostate Cancer Cells Is Blocked by Low-Dose Curcumin in Combination with Light IrradiationJochen Rutz, Aicha Benchellal, Wajdi Kassabra, et al.
Pageof 105